Last reviewed · How we verify

NCT07304076

Clinical Research on the Comparative Effectiveness and Safety of JHG002 Therapy for Chronic Low Back Pain: A Multicenter Randomized Controlled Trial

Recruiting now NA Last updated 25 February 2026
What this trial tests

NA trial testing Hominis placental pharmacopuncture in Chronic Low Back Pain (CLBP) in 96 participants. Currently enrolling.

Timeline
17 December 2025
Primary endpoint
28 November 2029
28 November 2029

Quick facts

Lead sponsorJaseng Medical Foundation
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment96
Start date17 December 2025
Primary completion28 November 2029
Estimated completion28 November 2029
Sites4 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Jaseng Medical Foundation

Who can join

Adults 19 to 70, any sex, with Chronic Low Back Pain (CLBP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multicenter randomized controlled trial

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Low Back Pain (CLBP)

Currently open trials in the same condition.

Other Jaseng Medical Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07304076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing